US Edition
£1million partnership aims to develop new treatments for congenital muscular dystrophy
Summary by LifeArc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
£1million partnership aims to develop new treatments for congenital muscular dystrophy
Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop potential treatments for congenital muscular dystrophy. Congenital muscular dystrophy includes a group of conditions that can lead to muscle weakness, reduced movement and tight joints. Symptoms can start from birth, or in the first few months of life, and there are currently no effective treatments. The first o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
